Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
Eur J Pediatr. 2024 Oct;183(10):4345-4350. doi: 10.1007/s00431-024-05699-w. Epub 2024 Jul 31.
The aim of this study was to perform a retrospective data analysis of established peripheral artery catheters (pAC) in extremely preterm infants. The primary outcome was the pAC life span and its correlation to gestational age, birth weight, localizations, and pAC removal. Retrospective data analysis of electronic patient records of all extremely preterm infants (born less than 28 weeks gestation) admitted to the neonatal intensive care unit in Graz (Austria) between January 2014 and December 2020. A total of 196 preterm infants with a median (IQR) gestational age of 25.7 (24.6-26.6) weeks and a birth weight of 730 (614-898) g were included. In 155 (79%) of these preterm infants, 286 pAC and six umbilical artery catheters were inserted successfully. The first pAC was inserted 2.5 (1.4-7.4) h after birth, and the median pAC life span was 57.5 (22.-107.2) h. Gestational age, birth weight, and catheter localization did not correlate with the pAC life span. The pAC localizations were the radial artery (63%), tibial posterior artery (21%), ulnar artery (6%), dorsal artery of the foot (6%), others (1%), and not documented (3%). Adverse reactions including temporarily impaired peripheral perfusion, local inflammation, extravasation, or bleeding were reported in 13% of all pAC, but none of these resulted in long-term sequelae. A median (IQR) of 9 (5-18) arterial blood samples were drawn via pAC, resulting in a notable reduction of pain stimuli.Conclusion: The use of pAC in extremely preterm infants is feasible and safe. Neither gestational age, birth weight nor localization did affect the life span of pAC. No long-term sequelae were observed, and pain events were reduced by using pAC for blood drawing. What is Known: • Peripheral artery catheters can be used for continuous blood pressure measurement and blood draw even in extremely preterm infants. • (Severe) adverse reactions such as bleeding, necrosis, or amputation occur between 1 and 4%. • What is New: • The median peripheral arty catheter life span is 58 h and is not affected by gestational age, birth weight, nor localization. • A median of nine blood samples can be taken per each single pAC and, therefore, prevent pain events in extremely preterm infants.
本研究旨在对极低出生体重儿(VLBW)已建立的外周动脉导管(pAC)进行回顾性数据分析。主要结局是 pAC 的寿命及其与胎龄、出生体重、置管部位和 pAC 拔除的相关性。对 2014 年 1 月至 2020 年 12 月在格拉茨(奥地利)新生儿重症监护病房(NICU)住院的所有极早产儿(胎龄<28 周)的电子病历进行回顾性数据分析。共纳入 196 例胎龄中位数(IQR)为 25.7(24.6-26.6)周、出生体重为 730(614-898)g 的早产儿。其中 155 例(79%)早产儿成功插入 286 根 pAC 和 6 根脐动脉导管。第 1 根 pAC 在出生后 2.5(1.4-7.4)h 时插入,pAC 的中位寿命为 57.5(22.-107.2)h。胎龄、出生体重和导管置管部位与 pAC 寿命无相关性。pAC 的置管部位为桡动脉(63%)、胫后动脉(21%)、尺动脉(6%)、足底背侧动脉(6%)、其他部位(1%)和未记录(3%)。所有 pAC 中均有 13%出现暂时外周灌注受损、局部炎症、外渗或出血等不良反应,但均无长期后遗症。通过 pAC 抽取中位数(IQR)为 9(5-18)次动脉血样,显著减少疼痛刺激。结论:在极早产儿中使用 pAC 是可行且安全的。胎龄、出生体重和置管部位均不影响 pAC 的寿命。未观察到长期后遗症,且使用 pAC 进行采血可减少疼痛事件。已知:• 外周动脉导管可用于连续血压测量和采血,即使在极早产儿中也是如此。•(严重)不良反应如出血、坏死或截肢发生率为 1%至 4%。• 新发现:• pAC 的中位外周动脉导管寿命为 58 h,不受胎龄、出生体重和置管部位的影响。• 每条 pAC 可抽取中位数为 9 次血样,因此可预防极早产儿的疼痛事件。